Bio-Techne (TECH) Declares $0.32 Quarterly Dividend; 0.5% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bio-Techne (TECH) Tops Q4 EPS by 25c
August 4, 2020 6:31 AM EDTBio-Techne (NASDAQ: TECH) reported Q4 EPS of $1.00, $0.25 better than the analyst estimate of $0.75. Revenue for the quarter came in at $175.8 million versus the consensus estimate of $163.91 million.
For earnings history and earnings-related data on Bio-Techne (TECH) click here.
... MoreBio-Techne (TECH) Adds Julie L. Bushman to Board
August 3, 2020 7:09 AM EDTBio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Julie L. Bushman to serve as an independent director on the company's board of directors, effective as of July 31, 2020. Following the appointment, the board of Bio-Techne will be comprised of ten directors, nine of... More
Bio-Techne (TECH) And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test
August 3, 2020 7:07 AM EDTBio-Techne Corporation (NASDAQ: TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced the anticipated launch of the COVID-SeroIndex, a Kantaro Quantitative SARS-CoV-2 IgG Antibody RUO kit. Bio-Techne and Kantaro will leverage a joint commercialization and distribution team to support rapid distribution of the assay to the vaccine development community. The COVID-SeroIndex test kit is expected to be available for research use in early August.
The COVID-SeroIndex test kit is an enzyme-linked immunosorbent assay, or ELISA, designed to measure the presence or... More
